Bivas-Benita Maytal, Romeijn Stefan, Junginger Hans E, Borchard Gerrit
Leiden/Amsterdam Center for Drug Research, Division of Pharmaceutical Technology, Leiden, The Netherlands.
Eur J Pharm Biopharm. 2004 Jul;58(1):1-6. doi: 10.1016/j.ejpb.2004.03.008.
Pulmonary gene delivery is thought to play an important role in treating genetically related diseases and may induce immunity towards pathogens entering the body via the airways. In this study we prepared poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles bearing polyethyleneimine (PEI) on their surface and characterized them for their potential in serving as non-viral gene carriers to the pulmonary epithelium. Particles that were synthesized at different PLGA-PEI ratios and loaded with DNA in several PEI-DNA ratios, exhibited narrow size distribution in all formulations, with mean particle sizes ranging between 207 and 231 nm. Zeta potential was strongly positive (above 30 mV) for all the PEI-DNA ratios examined and the loading efficiency exceeded 99% for all formulations. Internalization of the DNA-loaded PLGA-PEI nanoparticles was studied in the human airway submucosal epithelial cell line, Calu-3, and DNA was detected in the endo-lysosomal compartment 6 h after particles were applied. Cytotoxicity of these nanoparticles was dependent on the PEI-DNA ratio and best cell viability was achieved by PEI-DNA ratios 1:1 and 0.5:1. These findings demonstrate that PLGA-PEI nanoparticles are a potential new delivery system to carry genes to the lung epithelium.
肺基因递送被认为在治疗遗传相关疾病中发挥重要作用,并且可能诱导针对经气道进入体内的病原体的免疫反应。在本研究中,我们制备了表面带有聚乙烯亚胺(PEI)的聚(D,L-丙交酯-共-乙交酯)(PLGA)纳米颗粒,并对其作为肺上皮细胞非病毒基因载体的潜力进行了表征。以不同的PLGA-PEI比例合成并以几种PEI-DNA比例负载DNA的颗粒,在所有制剂中均表现出窄的粒径分布,平均粒径在207至231nm之间。对于所有检测的PEI-DNA比例,zeta电位均为强阳性(高于30mV),并且所有制剂的负载效率均超过99%。在人气道黏膜下上皮细胞系Calu-3中研究了负载DNA的PLGA-PEI纳米颗粒的内化情况,在应用颗粒6小时后,在内溶酶体区室中检测到了DNA。这些纳米颗粒的细胞毒性取决于PEI-DNA比例,并且通过PEI-DNA比例1:1和0.5:1可实现最佳的细胞活力。这些发现表明,PLGA-PEI纳米颗粒是一种将基因递送至肺上皮的潜在新递送系统。